SCHEMBL73637

SCHEMBL73637

[CH2]NC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dimethylamine SCHEMBL2412477 0.67
Dimethylamine SCHEMBL11441610 0.67
Dimethylamine SCHEMBL6030163 0.67 KDM4E (0.33)
Dimethylamine SCHEMBL632212 0.67
Dimethylamine SCHEMBL5341579 0.62
Dimethylamine SCHEMBL809651 0.62
Dimethylamine SCHEMBL12415750 0.61
Dimethylamine SCHEMBL5164633 0.61
Dimethylamine SCHEMBL1030 0.61
Dimethylamine SCHEMBL392668 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 11286 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025092976-A1 PROTEIN TRANSLATION INHIBITOR 映恩生物制药(苏州)有限公司 2025-05-08 WO claimed
WO-2025051241-A1 MACROCYCLIC COMPOUND AND ANTIBODY-DRUG CONJUGATE THEREOF 劲方医药科技(上海)股份有限公司 2025-03-13 WO claimed
CN-114514039-B Composition for transfecting nucleic acid molecules into cells comprising heterocyclic compounds grafted onto cationic polymers and uses thereof 宝利普拉斯生物转染公司 2025-02-25 CN claimed
CN-119278201-A Activators of effector T cells 奥隆制药 2025-01-07 CN claimed
CN-118748995-A 5-Pyrimidine carboxamide derivatives and methods of use thereof 亚根达医疗公司 2024-10-08 CN claimed
CN-118660875-A Protein tyrosine phosphatase inhibitors, compositions, and methods of use 百时美施贵宝公司 2024-09-17 CN claimed
CN-118344342-A Substituted polyaromatic ring derivatives, compositions and uses thereof 康迈迪森(北京)医药科技有限公司 2024-07-16 CN claimed
CN-118201916-A Piperazinylsulfonylaryl compounds for the treatment of bacterial infections 豪夫迈·罗氏有限公司 2024-06-14 CN claimed
CN-118161500-A Heterocyclic compounds as delta-5 desaturase inhibitors and methods of use 安进公司 2024-06-11 CN claimed
WO-2024114793-A1 SALT FORM AND CRYSTAL FORM OF UBIQUITINATION-SPECIFIC PROTEASE INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF 杭州普济远成生物医药科技有限公司 2024-06-06 WO claimed
EP-0059597-A2 Guanidino-substituted heterocyclic derivatives having histamine H-2 antagonist activity IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1982-09-08 EP claimed
EP-0055562-A2 Cephalosporin derivatives ICI PHARMA (FR) 1982-07-07 EP claimed
EP-0055099-A1 Penicillin derivatives ICI PHARMA (FR) 1982-06-30 EP claimed
EP-0039903-A2 8-Substituted pyrrolizidines and quaternary ammonium salts thereof SUNTORY KABUSHIKI KAISHA (JP) 1981-11-18 EP claimed
EP-0037971-A2 Trisubstituted cyanoguanidines, process for their preparation and their use as fungicides BAYER AG (DE) 1981-10-21 EP claimed
EP-0031708-A2 Cephalosporin derivatives, processes for their manufacture, pharmaceutical compositions containing them and intermediates therefor ICI PHARMA (FR) 1981-07-08 EP claimed
US-4246260-A ANTHELMINTICS BAYER AKTIENGESELLSCHAFT (DE) 1981-01-20 US claimed
US-4232030-A ANTIBIOTICS MERCK & CO., INC. (US) 1980-11-04 US claimed
US-4166114-A AMINOGLYCOSIDE ANTIBIOTIC DERIVATIVES AND METHOD OF USE SHIONOGI & CO., LTD. (JP) 1979-08-28 US claimed
EP-0001264-A1 Substituted N-methylene derivatives of thienamycin sulfoxide and sulfone and their preparation MERCK & CO. INC. (US) 1979-04-04 EP claimed